Clinical Trials Directory

Trials / Completed

CompletedNCT03679156

Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Hospital Hietzing · Academic / Other
Sex
All
Age
66 Years – 98 Years
Healthy volunteers
Not accepted

Summary

Purpose: To assess retinal pigment epithelial (RPE) and retinal structural changes in eyes with neovascular age-related macular degeneration (AMD) treated with anti-vascular endothelial growth factor (anti-VEGF) during long-term follow-up and to evaluate morphological markers potentially influencing prognosis. Methods: 18 patients (18 eyes) with neovascular AMD were recruited subsequent to completion the Avastin Versus Lucentis in Age Related Macular Degeneration (MANTA) study following a mean period of 84 months (range: 69-93 months). After receiving a loading dose of 3 intravitreal anti-VEGF injections subsequent to baseline of the MANTA study, patients were treated as-needed \[pro re nata (PRN)\]. Functional and morphological changes were assessed using spectral domain optical coherence tomography (SD-OCT).

Conditions

Interventions

TypeNameDescription
DEVICEOCTPatients were recruited, visual acuity and optical coherence tomography Pictures were taken

Timeline

Start date
2016-05-30
Primary completion
2016-11-02
Completion
2017-04-15
First posted
2018-09-20
Last updated
2018-09-20

Source: ClinicalTrials.gov record NCT03679156. Inclusion in this directory is not an endorsement.

Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term (NCT03679156) · Clinical Trials Directory